Postoperative Dialysis in Fontan Patients Undergoing Heart Transplant: How Predictive is the Pretransplant Serum Creatinine? Pediatr Transplant. 2025 Jun; 29(4):e70090. View Postoperative Dialysis in Fontan Patients Undergoing Heart Transplant: How Predictive is the Pretransplant Serum Creatinine? Abstract

Socioeconomic Status and Major Adverse Transplant Events in Pediatric Heart Transplant Recipients. JAMA Netw Open. 2024 Oct 01; 7(10):e2437255. View Socioeconomic Status and Major Adverse Transplant Events in Pediatric Heart Transplant Recipients. Abstract

Sacubitril/Valsartan in Pediatric Heart Failure (PANORAMA-HF): A Randomized, Multicenter, Double-Blind Trial. Circulation. 2024 Nov 26; 150(22):1756-1766. View Sacubitril/Valsartan in Pediatric Heart Failure (PANORAMA-HF): A Randomized, Multicenter, Double-Blind Trial. Abstract

International Society for Heart and Lung Transplantation Guidelines for the Evaluation and Care of Cardiac Transplant Candidates-2024. J Heart Lung Transplant. 2024 Oct; 43(10):1529-1628.e54. View International Society for Heart and Lung Transplantation Guidelines for the Evaluation and Care of Cardiac Transplant Candidates-2024. Abstract

Improving Mechanical Circulatory Support Outcomes in Failing Bidirectional Glenn Physiology. Pediatr Cardiol. 2024 Jul 19. View Improving Mechanical Circulatory Support Outcomes in Failing Bidirectional Glenn Physiology. Abstract

Pathology of explanted pediatric hearts: An 11-year study. Population characteristics and implications for outcomes. Pediatr Transplant. 2024 Jun; 28(4):e14742. View Pathology of explanted pediatric hearts: An 11-year study. Population characteristics and implications for outcomes. Abstract

Impact of a positive crossmatch on pediatric heart transplant outcomes. J Heart Lung Transplant. 2024 Jun; 43(6):963-972. View Impact of a positive crossmatch on pediatric heart transplant outcomes. Abstract

Detecting and managing cardiac allograft vasculopathy within the transition from pediatric to adult heart transplantation care: Lighting the pathway ahead. J Heart Lung Transplant. 2024 02; 43(2):238-240. View Detecting and managing cardiac allograft vasculopathy within the transition from pediatric to adult heart transplantation care: Lighting the pathway ahead. Abstract

Medium-term Outcomes in Pediatric Heart Transplant Recipients Managed Using a Steroid Avoidance Immune Suppression Protocol. Transplantation. 2024 01 01; 108(1):e8-e14. View Medium-term Outcomes in Pediatric Heart Transplant Recipients Managed Using a Steroid Avoidance Immune Suppression Protocol. Abstract

Survivors of Pediatric Hematopoietic Stem Cell Transplantation Exhibit Progressive Diastolic Dysfunction Over Years of Follow-Up. Transplant Cell Ther. 2023 Dec; 29(12):774.e1-774.e8. View Survivors of Pediatric Hematopoietic Stem Cell Transplantation Exhibit Progressive Diastolic Dysfunction Over Years of Follow-Up. Abstract

ABO-Incompatible Heart Transplantation: Where Science, Society, and Policy Collide. J Card Fail. 2024 Mar; 30(3):486-487. View ABO-Incompatible Heart Transplantation: Where Science, Society, and Policy Collide. Abstract

External assessment and refinement of a population pharmacokinetic model to guide tacrolimus dosing in pediatric heart transplant. Pharmacotherapy. 2023 07; 43(7):650-658. View External assessment and refinement of a population pharmacokinetic model to guide tacrolimus dosing in pediatric heart transplant. Abstract

Fecal Microbiota Transplant in Pediatric Solid Organ Transplant Recipients. Transplantation. 2023 09 01; 107(9):2073-2077. View Fecal Microbiota Transplant in Pediatric Solid Organ Transplant Recipients. Abstract

The teammate trial: Study design and rationale tacrolimus and everolimus against tacrolimus and MMF in pediatric heart transplantation using the major adverse transplant event (MATE) score. Am Heart J. 2023 06; 260:100-112. View The teammate trial: Study design and rationale tacrolimus and everolimus against tacrolimus and MMF in pediatric heart transplantation using the major adverse transplant event (MATE) score. Abstract

Apixaban Anticoagulation in Children and Young Adults Supported With the HeartMate 3 Ventricular Assist Device. ASAIO J. 2023 06 01; 69(6):e267-e269. View Apixaban Anticoagulation in Children and Young Adults Supported With the HeartMate 3 Ventricular Assist Device. Abstract

Equity factors in pediatric transplant listing: Initial findings from a single center review. Pediatr Transplant. 2023 03; 27(2):e14467. View Equity factors in pediatric transplant listing: Initial findings from a single center review. Abstract

The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients. J Heart Lung Transplant. 2023 05; 42(5):e1-e141. View The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients. Abstract

Prognostic Value of Exercise Stress Echocardiography in Pediatric Cardiac Transplant Recipients. J Am Soc Echocardiogr. 2022 11; 35(11):1133-1138.e2. View Prognostic Value of Exercise Stress Echocardiography in Pediatric Cardiac Transplant Recipients. Abstract

The Burden of Pediatric Heart Failure That Lies Just Under the Surface. J Am Coll Cardiol. 2022 05 17; 79(19):1929-1931. View The Burden of Pediatric Heart Failure That Lies Just Under the Surface. Abstract

Experience with live attenuated varicella vaccination in pediatric heart transplant recipients: Considering a new path forward. J Heart Lung Transplant. 2022 08; 41(8):1027-1028. View Experience with live attenuated varicella vaccination in pediatric heart transplant recipients: Considering a new path forward. Abstract

Waitlist Outcomes for Children With Congenital Heart Disease: Lessons Learned From Over 5000 Heart Transplant Listings in the United States. J Card Fail. 2022 06; 28(6):982-990. View Waitlist Outcomes for Children With Congenital Heart Disease: Lessons Learned From Over 5000 Heart Transplant Listings in the United States. Abstract

Pediatric heart transplant waiting times in the United States since the 2016 allocation policy change. Am J Transplant. 2022 03; 22(3):833-842. View Pediatric heart transplant waiting times in the United States since the 2016 allocation policy change. Abstract

Giant Cell Myocarditis and Left Ventricular Apical Aneurysm in a Child With Severe Combined Immunodeficiency. Circ Cardiovasc Imaging. 2021 12; 14(12):1157-1158. View Giant Cell Myocarditis and Left Ventricular Apical Aneurysm in a Child With Severe Combined Immunodeficiency. Abstract

Giant Cell Myocarditis in Children: Elusive Giant Cells Might Not Be the Only Clue. Pediatr Dev Pathol. 2022 Mar-Apr; 25(2):197-202. View Giant Cell Myocarditis in Children: Elusive Giant Cells Might Not Be the Only Clue. Abstract

Clinical and hemodynamic characteristics of the pediatric failing Fontan. J Heart Lung Transplant. 2021 12; 40(12):1529-1539. View Clinical and hemodynamic characteristics of the pediatric failing Fontan. Abstract

ISHLT consensus statement for the selection and management of pediatric and congenital heart disease patients on ventricular assist devices Endorsed by the American Heart Association. J Heart Lung Transplant. 2021 08; 40(8):709-732. View ISHLT consensus statement for the selection and management of pediatric and congenital heart disease patients on ventricular assist devices Endorsed by the American Heart Association. Abstract

Assessment and Treatment of a Young Adult with Congenital Heart Disease and ADHD. J Dev Behav Pediatr. 2021 05 01; 42(4):340-342. View Assessment and Treatment of a Young Adult with Congenital Heart Disease and ADHD. Abstract

Hepatorenal dysfunction assessment with the Model for End-Stage Liver Disease Excluding INR score predicts worse survival after heart transplant in pediatric Fontan patients. J Thorac Cardiovasc Surg. 2022 04; 163(4):1462-1473.e12. View Hepatorenal dysfunction assessment with the Model for End-Stage Liver Disease Excluding INR score predicts worse survival after heart transplant in pediatric Fontan patients. Abstract

Retrospective Analysis of Clinical Genetic Testing in Pediatric Primary Dilated Cardiomyopathy: Testing Outcomes and the Effects of Variant Reclassification. J Am Heart Assoc. 2020 06 02; 9(11):e016195. View Retrospective Analysis of Clinical Genetic Testing in Pediatric Primary Dilated Cardiomyopathy: Testing Outcomes and the Effects of Variant Reclassification. Abstract

The ABO-incompatible paradigm shifts only as far as allocation policy allows. J Heart Lung Transplant. 2020 07; 39(7):636-638. View The ABO-incompatible paradigm shifts only as far as allocation policy allows. Abstract

Brighter Future for Children with Congenital Heart Disease Requiring Heart Transplantation? A UNOS Registry Analysis over the Last Three Decades. J Heart Lung Transplant. 2020 Apr; 39(4S):S206-S207. View Brighter Future for Children with Congenital Heart Disease Requiring Heart Transplantation? A UNOS Registry Analysis over the Last Three Decades. Abstract

The TEAMMATE Trial: Study Design and Rationale of the First Pediatric Heart Transplant Randomized Clinical Trial. J Heart Lung Transplant. 2020 Apr; 39(4S):S207-S208. View The TEAMMATE Trial: Study Design and Rationale of the First Pediatric Heart Transplant Randomized Clinical Trial. Abstract

Coagulation Monitoring Correlation with Bivalirudin Dosing in Pediatric Ventricular Assist Device Support. J Heart Lung Transplant. 2020 Apr; 39(4S):S467-S468. View Coagulation Monitoring Correlation with Bivalirudin Dosing in Pediatric Ventricular Assist Device Support. Abstract

Marijuana in pediatric and adult congenital heart disease heart transplant listing: A survey of provider practices and attitudes. Pediatr Transplant. 2020 03; 24(2):e13640. View Marijuana in pediatric and adult congenital heart disease heart transplant listing: A survey of provider practices and attitudes. Abstract

Association of Clinical Rejection Versus Rejection on Protocol Biopsy With Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients. Transplantation. 2020 01; 104(1):e31-e37. View Association of Clinical Rejection Versus Rejection on Protocol Biopsy With Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients. Abstract

Use of the terminal complement inhibitor eculizumab in paediatric heart transplant recipients. Cardiol Young. 2020 Jan; 30(1):107-113. View Use of the terminal complement inhibitor eculizumab in paediatric heart transplant recipients. Abstract

Current evaluation and management of plastic bronchitis in the pediatric population. Int J Pediatr Otorhinolaryngol. 2020 Mar; 130:109799. View Current evaluation and management of plastic bronchitis in the pediatric population. Abstract

Myocardial Infarct After Marijuana Inhalation in a 16-year-old Adolescent Boy. Pediatr Dev Pathol. 2019 Jan-Feb; 22(1):80-86. View Myocardial Infarct After Marijuana Inhalation in a 16-year-old Adolescent Boy. Abstract

Heart failure after the Norwood procedure: An analysis of the Single Ventricle Reconstruction Trial. J Heart Lung Transplant. 2018 07; 37(7):879-885. View Heart failure after the Norwood procedure: An analysis of the Single Ventricle Reconstruction Trial. Abstract

Managing risk of surgical procedures in pediatric transplant recipients taking mTOR inhibitors: What is the optimal strategy? Pediatr Transplant. 2018 02; 22(1). View Managing risk of surgical procedures in pediatric transplant recipients taking mTOR inhibitors: What is the optimal strategy? Abstract

Clinical practice patterns are relatively uniform between pediatric heart transplant centers: A survey-based assessment. Pediatr Transplant. 2017 Aug; 21(5). View Clinical practice patterns are relatively uniform between pediatric heart transplant centers: A survey-based assessment. Abstract

The Evolution of a Pediatric Ventricular Assist Device Program: The Boston Children's Hospital Experience. Pediatr Cardiol. 2017 Jun; 38(5):1032-1041. View The Evolution of a Pediatric Ventricular Assist Device Program: The Boston Children's Hospital Experience. Abstract

Development and validation of a major adverse transplant event (MATE) score to predict late graft loss in pediatric heart transplantation. J Heart Lung Transplant. 2018 04; 37(4):441-450. View Development and validation of a major adverse transplant event (MATE) score to predict late graft loss in pediatric heart transplantation. Abstract

Into the hearts of babes: Stem cell therapy for pediatric heart failure. J Heart Lung Transplant. 2017 08; 36(8):830-832. View Into the hearts of babes: Stem cell therapy for pediatric heart failure. Abstract

Dilated Cardiomyopathy in a 2-Year-Old Infant. Clin Chem. 2017 01; 63(1):433-435. View Dilated Cardiomyopathy in a 2-Year-Old Infant. Abstract

Vascular endothelial growth factor A is associated with the subsequent development of moderate or severe cardiac allograft vasculopathy in pediatric heart transplant recipients. J Heart Lung Transplant. 2017 Apr; 36(4):434-442. View Vascular endothelial growth factor A is associated with the subsequent development of moderate or severe cardiac allograft vasculopathy in pediatric heart transplant recipients. Abstract

Cholesterol efflux capacity of high-density lipoprotein correlates with survival and allograft vasculopathy in cardiac transplant recipients. J Heart Lung Transplant. 2016 11; 35(11):1295-1302. View Cholesterol efflux capacity of high-density lipoprotein correlates with survival and allograft vasculopathy in cardiac transplant recipients. Abstract

Is Endomyocardial Biopsy a Safe and Useful Procedure in Children with Suspected Cardiomyopathy? Pediatr Cardiol. 2016 Oct; 37(7):1200-10. View Is Endomyocardial Biopsy a Safe and Useful Procedure in Children with Suspected Cardiomyopathy? Abstract

Finding the correct role for heart transplant in the treatment of hypoplastic left heart syndrome. J Heart Lung Transplant. 2016 Mar; 35(3):299-300. View Finding the correct role for heart transplant in the treatment of hypoplastic left heart syndrome. Abstract

What Is the Role of Developmental Disability in Patient Selection for Pediatric Solid Organ Transplantation? Am J Transplant. 2016 Mar; 16(3):767-72. View What Is the Role of Developmental Disability in Patient Selection for Pediatric Solid Organ Transplantation? Abstract

Use of [18F]FDG Positron Emission Tomography to Monitor the Development of Cardiac Allograft Rejection. Transplantation. 2015 Sep; 99(9):e132-9. View Use of [18F]FDG Positron Emission Tomography to Monitor the Development of Cardiac Allograft Rejection. Abstract

Multicenter Analysis of Immune Biomarkers and Heart Transplant Outcomes: Results of the Clinical Trials in Organ Transplantation-05 Study. Am J Transplant. 2016 Jan; 16(1):121-36. View Multicenter Analysis of Immune Biomarkers and Heart Transplant Outcomes: Results of the Clinical Trials in Organ Transplantation-05 Study. Abstract

Summary of the 2015 International Paediatric Heart Failure Summit of Johns Hopkins All Children's Heart Institute. Cardiol Young. 2015 Aug; 25 Suppl 2:8-30. View Summary of the 2015 International Paediatric Heart Failure Summit of Johns Hopkins All Children's Heart Institute. Abstract

Emerging science in paediatric heart transplantation: donor allocation, biomarkers, and the quest for evidence-based medicine. Cardiol Young. 2015 Aug; 25 Suppl 2:117-23. View Emerging science in paediatric heart transplantation: donor allocation, biomarkers, and the quest for evidence-based medicine. Abstract

Translational implications of endothelial cell dysfunction in association with chronic allograft rejection. Pediatr Nephrol. 2016 Jan; 31(1):41-51. View Translational implications of endothelial cell dysfunction in association with chronic allograft rejection. Abstract

Circulating donor-derived cell-free DNA: a true biomarker for cardiac allograft rejection? Ann Transl Med. 2015 Mar; 3(4):47. View Circulating donor-derived cell-free DNA: a true biomarker for cardiac allograft rejection? Abstract

Safety and efficacy of radiofrequency wire recanalization of chronic central venous occlusions. J Vasc Access. 2015 Jul-Aug; 16(4):309-14. View Safety and efficacy of radiofrequency wire recanalization of chronic central venous occlusions. Abstract

Antibody depletion for the treatment of crossmatch-positive pediatric heart transplant recipients. Pediatr Transplant. 2013 Nov; 17(7):661-9. View Antibody depletion for the treatment of crossmatch-positive pediatric heart transplant recipients. Abstract

Effect of inhaled iloprost on the exercise function of Fontan patients: a demonstration of concept. Int J Cardiol. 2013 Oct 03; 168(3):2435-40. View Effect of inhaled iloprost on the exercise function of Fontan patients: a demonstration of concept. Abstract

VEGF-C, VEGF-A and related angiogenesis factors as biomarkers of allograft vasculopathy in cardiac transplant recipients. J Heart Lung Transplant. 2013 Jan; 32(1):120-8. View VEGF-C, VEGF-A and related angiogenesis factors as biomarkers of allograft vasculopathy in cardiac transplant recipients. Abstract

Key Features of the Intragraft Microenvironment that Determine Long-Term Survival Following Transplantation. Front Immunol. 2012; 3:54. View Key Features of the Intragraft Microenvironment that Determine Long-Term Survival Following Transplantation. Abstract

Endomyocardial biopsy and selective coronary angiography are low-risk procedures in pediatric heart transplant recipients: results of a multicenter experience. J Heart Lung Transplant. 2012 Apr; 31(4):398-409. View Endomyocardial biopsy and selective coronary angiography are low-risk procedures in pediatric heart transplant recipients: results of a multicenter experience. Abstract

Sudden death after pediatric heart transplantation: analysis of data from the Pediatric Heart Transplant Study Group. J Heart Lung Transplant. 2011 Dec; 30(12):1395-402. View Sudden death after pediatric heart transplantation: analysis of data from the Pediatric Heart Transplant Study Group. Abstract

Changes in echocardiographic measures of systolic and diastolic function in children 1 year after hematopoietic SCT. Bone Marrow Transplant. 2011 Dec; 46(12):1532-9. View Changes in echocardiographic measures of systolic and diastolic function in children 1 year after hematopoietic SCT. Abstract

Variant translocation with a deletion of derivative (9q) in a case of Philadelphia chromosome positive (Ph +) essential thrombocythemia (ET), a variant of chronic myelogenous leukemia (CML) with a poor prognosis. Leuk Lymphoma. 2005 Dec; 46(12):1801-6. View Variant translocation with a deletion of derivative (9q) in a case of Philadelphia chromosome positive (Ph +) essential thrombocythemia (ET), a variant of chronic myelogenous leukemia (CML) with a poor prognosis. Abstract